Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laborit study of sodium oxybate for catatonia
NL-OMON60946Phase 3Suspended
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of sodium oxybate in catatonia (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Response rate after 4 days of treatment. Started Nov 2024; status: suspended.
02
Drugs
sodium oxybate
03
Conditions
catatonia
Beyond the preview
Go deeper on NL-OMON60946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60946.